Literature DB >> 3258369

Radiochemical purity of [99mTc]HM-PAO.

J R Ballinger, R H Reid, K Y Gulenchyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3258369

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  Regional changes in forebrain activation during the early and late phase of formalin nociception: analysis using cerebral blood flow in the rat.

Authors:  T J Morrow; P E Paulson; P J Danneman; K L Casey
Journal:  Pain       Date:  1998-04       Impact factor: 6.961

2.  Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease.

Authors:  M Papós; F Nagy; J Láng; L Csernay
Journal:  Eur J Nucl Med       Date:  1993-09

3.  In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.

Authors:  M Ecclestone; A Proulx; J R Ballinger; B Gerson; R H Reid; K Y Gulenchyn
Journal:  Eur J Nucl Med       Date:  1990

4.  Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease.

Authors:  M Papos; F Nagy; G Narai; M Rajtar; G Szantai; J Lang; L Csernay
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

5.  Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.

Authors:  R B Moore; J D Chapman; A D Mokrzanowski; M R Arnfield; M S McPhee; A J McEwan
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.